Lack of effects of guanfacine on executive and memory functions in healthy male volunteers
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Rationale Guanfacine is an alpha2-adrenergic receptor agonist that has been shown to have beneficial effects on working memory and attentional functions in monkeys and in patients with attention deficit hyperactivity disorder.Objectives The aim of this study was to further investigate the cognitive-enhancing properties of guanfacine using an established battery of tasks measuring executive and memory functions.Methods Sixty healthy male volunteers were randomised into three groups. Cognitive testing was performed from +2 to +4 h after double-blind administration of a single oral dose of 1 or 2 mg of guanfacine or placebo.Results Systolic blood pressure was significantly reduced by both doses of guanfacine at the end of the testing session. There were no statistically significant effects on any of the cognitive measures. Two trend effects were observed with poorer performance on digit span backward and slower 'Go' reaction times after guanfacine.Conclusion This study found no improvement of prefrontal memory or executive functions after guanfacine. Negative effects on blood pressure and trend effects on digit span backward and go reaction time indicate a mild sedative effect of guanfacine at these doses, possibly via mechanisms of autoreceptor down-regulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, it can be challenging to improve cognition in healthy subjects (Muller et al., 2005), possibly related to ceiling effects on neuronal firing”
From Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species (2020) · cites this paper as Muller et al., 2005
In the citing paper
“However, guanfacine did not improve impulsivity in healthy volunteers (Muller et al 2005)”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Muller et al 2005
Citations
Cites
Statistical Methods for Psychology.
Gudgeon, A. C., & Howell, D. C. (1994) · The Statistician · doi:10.2307/2348956 · Cited by 8,278
The Neuropsychological Assessment
Ogden, J. A. (2005) · Fractured Minds · doi:10.1093/oso/9780195171358.003.0002 · Cited by 4,364
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Principles of Frontal Lobe Function
(2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134971.001.0001 · Cited by 1,665
Planning and spatial working memory following frontal lobe lesions in man
Owen, A. M., Downes, J. J., Sahakian, B. J., Polkey, C. E., & Robbins, T. W. (1990) · Neuropsychologia · doi:10.1016/0028-3932(90)90137-d · Cited by 1,245
Self-citationGroup reaction time distributions and an analysis of distribution statistics.
Ratcliff, R. (1979) · Psychological Bulletin · doi:10.1037//0033-2909.86.3.446 · Cited by 1,031
Sonuga-Barke, E. J. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.008 · Cited by 962
Decision-making processes following damage to the prefrontal cortex
Manes, F., Sahakian, B., Clark, L., Rogers, R., Antoun, N., Aitken, M., & Robbins, T. (2002) · Brain · doi:10.1093/brain/awf049 · Cited by 799
Self-citationComputerized assessment in neuropsychiatry using CANTAB: discussion paper.
Sahakian, B. J., & Owen, A. M. (1992) · Europe PMC (PubMed Central) · Cited by 793
Self-citationROBBINS, T. W., JAMES, M., OWEN, A. M., SAHAKIAN, B. J., LAWRENCE, A. D., MCINNES, L., & RABBITT, P. M. A. (1998) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617798455073 · Cited by 611
Self-citationScahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., Arnsten, A. F. T., Cohen, D. J., & Leckman, J. F. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1067 · Cited by 588
Barkley, R. A. (1997) · Psychological Bulletin · doi:10.1037//0033-2909.121.1.65 · Cited by 580 · cited 1×
“Impaired motor inhibition (as indicated by increased SSRT) is a core cognitive deficit in ADHD (Barkley 1997; Sonuga-Barke 2005) and is improved by psychostimulant treatment.”
BackgroundOwen, A. M., Sahakian, B. J., Semple, J., Polkey, C. E., & Robbins, T. W. (1995) · Neuropsychologia · doi:10.1016/0028-3932(94)00098-a · Cited by 525
Self-citationCognitive enhancing effects of modafinil in healthy volunteers
Turner, D. C., Robbins, T. W., Clark, L., Aron, A. R., Dowson, J., & Sahakian, B. J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1250-8 · Cited by 515
Self-citationNoradrenergic mechanisms in neurodegenerative diseases: a theory
Marien, M. R., Colpaert, F. C., & Rosenquist, A. C. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.02.002 · Cited by 414
Chemical neuromodulation of frontal-executive functions in humans and other animals
Robbins, T. W. (2000) · Experimental Brain Research · doi:10.1007/s002210000407 · Cited by 396
Self-citationMethylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder
Aron, A. R., Dowson, J. H., Sahakian, B. J., & Robbins, T. W. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00609-7 · Cited by 391
Self-citationArnsten, A., Cai, J., & Goldman-Rakic, P. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-11-04287.1988 · Cited by 391 · cited 1×
“In monkeys, guanfacine improved working memory and attentional functions in a dose-dependent manner; facilitatory effects were more prominent in elderly monkeys with presumed noradrenaline deficiency (Arnsten et al. 1988; Franowicz and Arnsten 1998).”
BackgroundEffects of methylphenidate on spatial working memory and planning in healthy young adults
Elliott, R., Sahakian, B. J., Matthews, K., Bannerjea, A., Rimmer, J., & Robbins, T. W. (1997) · Psychopharmacology · doi:10.1007/s002130050284 · Cited by 389
Self-citationThe action of sedatives on brain stem oculomotor systems in man
Norris, H. (1971) · Neuropharmacology · doi:10.1016/0028-3908(71)90039-6 · Cited by 388
Detecting Dementia: Novel Neuropsychological Markers of Preclinical Alzheimer’s Disease
Blackwell, A. D., Sahakian, B. J., Vesey, R., Semple, J. M., Robbins, T. W., & Hodges, J. R. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000074081 · Cited by 341
Self-citationAn Open Trial of Guanfacine in the Treatment of Attention-Deficit Hyperactivity Disorder
Hunt, R. D., Arnsten, A. F. T., & Asbell, M. D. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199501000-00013 · Cited by 308
Clark, L., Manes, F., Antoun, N., Sahakian, B. J., & Robbins, T. W. (2003) · Neuropsychologia · doi:10.1016/s0028-3932(03)00081-2 · Cited by 303
Self-citationTurner, D. C., Clark, L., Dowson, J., Robbins, T. W., & Sahakian, B. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.008 · Cited by 301
Self-citationCoull, J. T., Nobre, A. C., & Frith, C. D. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.1.73 · Cited by 298 · cited 3×
“Dose selection and the timing of test administration were based on previous cognitive studies in healthy volunteers (Jäkälä et al. 1999a–c; Coull et al. 2001) and clinical studies in patients with hypertension (Cornish 1988; Mosqueda-Garcia 1990) and ADHD (Scahill et al. 2001; Taylor and Russo…”
BackgroundMethodEffects of methylphenidate on inhibitory control in hyperactive children
Tannock, R., Schachar, R. J., Carr, R. P., Chajczyk, D., & Logan, G. D. (1989) · Journal of Abnormal Child Psychology · doi:10.1007/bf00916508 · Cited by 290
Rogers, R. D., Blackshaw, A. J., Middleton, H. C., Matthews, K., Hawtin, K., Crowley, C., Hopwood, A., Wallace, C., Deakin, J. F. W., Sahakian, B. J., et al. (1999) · Psychopharmacology · doi:10.1007/pl00005494 · Cited by 289 · cited 5×
“Executive functions were tested by two novel variants of CANTAB tasks that also allow for greater sensitivity: a three-dimensional version of the attentional set-shifting task (3DIDED) (Rogers et al. 1999) and the ‘one-touch’ version of the SoC spatial planning task (Owen et al. 1995).”
MethodSelf-citationMehta, M. A., Goodyer, I. M., & Sahakian, B. J. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.00221.x · Cited by 259
Self-citationNeural substrates of decision making in adults with attention deficit hyperactivity disorder
Ernst, M., Kimes, A. S., London, E. D., Matochik, J. A., Eldreth, D., Tata, S., Contoreggi, C., Leff, M., & Bolla, K. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.6.1061 · Cited by 254 · cited 2×
“There is also preliminary evidence for decision-making deficits in ADHD (Ernst et al. 2003), and it has been reported that noradrenergic blockade with propranolol reduces feedback processing on a gambling task (Rogers et al.”
BackgroundEvidence-based pharmacotherapy for attention-deficit hyperactivity disorder
Biederman, J., Spencer, T., & Wilens, T. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003973 · Cited by 253 · cited 1×
“Although there is no doubt that psychostimulants are effective in ADHD, around 30% of patients do not adequately respond or cannot tolerate treatment (Biederman et al. 2004).”
BackgroundCHAPPELL, P. B., RIDDLE, M. A., SCAHILL, L., LYNCH, K. A., SCHULTZ, R., ARNSTEN, A., LECKMAN, J. F., & COHEN, D. J. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199509000-00010 · Cited by 250 · cited 4×
“Guanfacine is proposed as a potential treatment for ADHD, with positive findings in open (Chappell et al. 1995; Horrigan and Barnhill 1995; Hunt et al. 1995; Posey et al. 2004) and controlled studies (Scahill et al. 2001; Taylor and Russo 2001; Cummings et al. 2002).”
BackgroundInfluentialMehta, M. A., Sahakian, B. J., McKenna, P. J., & Robbins, T. W. (1999) · Psychopharmacology · doi:10.1007/s002130051102 · Cited by 223 · cited 1×
“PRM Pattern Recognition Memory: a computerised dual-choice test of abstract visual pattern recognition Mehta et al. 1999 Percentage correct, response latency”
Self-citationTaylor, F. B., & Russo, J. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00015 · Cited by 189 · cited 6×
“Beneficial effects of guanfacine in patients with ADHD included improved response inhibition in a Stroop task (Taylor and Russo 2001) and better performance on a continuous performance task (Scahill et al. 2001).”
BackgroundMethodResultInfluentialGuanfacine, But Not Clonidine, Improves Planning and Working Memory Performance in Humans
Jäkälä, P. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00127-4 · Cited by 189
Franowicz, J. S., Kessler, L. E., Borja, C. M. D., Kobilka, B. K., Limbird, L. E., & Arnsten, A. F. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08771.2002 · Cited by 185
Coull, J. T., Jones, M. E. P., Egan, T. D., Frith, C., & Maze, M. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.12.022 · Cited by 175
Factor analysis of analogue scales measuring subjective feelings before and after sleep
HERBERT, M., JOHNS, M. W., & DORÉ, C. (1976) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1976.tb02388.x · Cited by 154
Avery, R. A., Franowicz, J. S., Studholme, C., van Dyck, C. H., & Arnsten, A. F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00111-1 · Cited by 151
Overtoom, C. C. E., Verbaten, M. N., Kemner, C., Kenemans, J. L., van Engeland, H., Buitelaar, J. K., van der Molen, M. W., van der Gugten, J., Westenberg, H. G. M., Maes, R. A. A., et al. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00097-4 · Cited by 151
Adrenergic targets for the treatment of cognitive deficits in schizophrenia
Arnsten, A. F. T. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1724-3 · Cited by 141
Contrasting effects of clonidine and diazepam on tests of working memory and planning
Coull, J. T., Middleton, H. C., Robbins, T. W., & Sahakian, B. J. (1995) · Psychopharmacology · doi:10.1007/bf02311179 · Cited by 135
Self-citationPosey, D. J., Puntney, J. I., Sasher, T. M., Kem, D. L., & McDougle, C. J. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/1044546041649084 · Cited by 127 · cited 6×
“Guanfacine is proposed as a potential treatment for ADHD, with positive findings in open (Chappell et al. 1995; Horrigan and Barnhill 1995; Hunt et al. 1995; Posey et al. 2004) and controlled studies (Scahill et al.”
BackgroundMethodInfluentialFranowicz, J. S., & Arnsten, A. F. T. (1998) · Psychopharmacology · doi:10.1007/s002130050533 · Cited by 120
Neuropsychiatric Effects of Guanfacine in Children With Mild Tourette Syndrome: A Pilot Study
Cummings, D. D., Singer, H. S., Krieger, M., Miller, T. L., & Mahone, E. M. (2002) · Clinical Neuropharmacology · doi:10.1097/00002826-200211000-00009 · Cited by 120
Guanfacine for Treatment of Attention-Deficit Hyperactivity Disorder in Boys
HORRIGAN, J. P., & BARNHILL, L. J. (1995) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1995.5.215 · Cited by 117
Guanfacine treatment of cognitive impairment in schizophrenia
Friedman, J. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00249-4 · Cited by 113 · cited 2×
“In Alzheimer’s disease (Crook et al. 1992), Parkinson’s disease (Sagar 1999) and schizophrenia (Friedman et al. 2001; Mehta 2002), guanfacine has been studied without conclusive results.”
BackgroundEffects of beta-adrenoceptor blockade on components of human decision-making
Rogers, R. D., Lancaster, M., Wakeley, J., & Bhagwagar, Z. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1641-5 · Cited by 108
Sorkin, E. M., & Heel, R. C. (1986) · Drugs · doi:10.2165/00003495-198631040-00003 · Cited by 106
Pharmacological manipulation of human working memory
Barch, D. M. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1732-3 · Cited by 99
Atomoxetine, a Novel Treatment for Attention‐Deficit—Hyperactivity Disorder
Christman, A. K., Fermo, J. D., & Markowitz, J. S. (2004) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.11.1020.36146 · Cited by 97
Neurochemical Modulation of Prefrontal Cortical Function in Humans and Animals
Arnsten, A. F. T., & Robbins, T. W. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134971.003.0004 · Cited by 90
Self-citationJäkälä, P. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00055-4 · Cited by 63
Noradrenergic blockade and numeric working memory in humans
Müller, U., Mottweiler, E., & Bublak, P. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105048888 · Cited by 43
Self-citationIdazoxan potentiates rather than antagonizes some of the cognitive effects of clonidine
Middleton, H. C., Sharma, A., Agouzoul, D., Sahakian, B. J., & Robbins, T. W. (1999) · Psychopharmacology · doi:10.1007/s002130051074 · Cited by 41
Self-citationDecision making in humans: the effect of manipulating the central noradrenergic system
O'Carroll, R. E. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.3.376 · Cited by 41
Potential Noradrenergic Targets for Cognitive Enhancement in Schizophrenia
Friedman, J. I., Stewart, D. G., & Gorman, J. M. (2004) · CNS Spectrums · doi:10.1017/s1092852900009330 · Cited by 41
Costs and benefits of strategy construction in a speeded discrimination task
Logan, G. D., Zbrodoff, N. J., & Fostey, A. R. W. (1983) · Memory & Cognition · doi:10.3758/bf03196985 · Cited by 29
Franowicz, J. S., & Arnsten, A. F. T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1110-6 · Cited by 26
Morrow, B. A., George, T. P., & Roth, R. H. (2004) · Brain Research · doi:10.1016/j.brainres.2004.08.057 · Cited by 24
The α2A-Adrenergic Agonist Guanfacine Improves Visuomotor Associative Learning in Monkeys
Wang, M., Ji, J., & Li, B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300278 · Cited by 20
Guanfacine: A Second Generation α2-Adrenergic Blocker
Mosqueda‐Garcia, R. (1990) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199001000-00016 · Cited by 19
Noradrenergic intervention in Alzheimer's disease.
Crook, T. H., Wilner, E., Rothwell, A., WINTERLING, D., & McEntee, W. J. (1992) · PubMed · Cited by 18
(1988) · PubMed · Cited by 15
Where Do We Go from Here? The Importance of Initial Values,
Mehta, M. A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00359-7 · Cited by 9
SAGAR, H. J. (1999) · PubMed · Cited by 6
Research works printed but not linked: 2
- Jäkälä P, Sirviö J, Riekkinen M, Koivisto E, Kejonen K, Vanhanen M, Riekkinen P Jr (1999c) Guanfacine and clonidine, alpha 2-agonists, improve paired associates learning, but not delayed matching to sample, in humans. Neuropsychopharmacology 20:119–130 · DOI · Paper page
- Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS (2004) Neuropsychological assessment, 4th edn. Oxford University Press, New York
Cited by
Inhibition and impulsivity: behavioral and neural basis of response control
Bari, A., & Robbins, T. W. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.005 · Cited by 1,921
Self-citationAdrenergic pharmacology and cognition: Focus on the prefrontal cortex
Ramos, B. P., & Arnsten, A. F. T. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.006 · Cited by 641
“,1999b), although this effect was not replicated in a study of younger, healthy subjects (Muller et al., 2005).”
BackgroundResultEagle, D. M., Bari, A., & Robbins, T. W. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1127-6 · Cited by 548
“cocaine, amphetamine, methamphetamine), and is also seen as a useful behavioural marker of genetic risk factors (Aron 2007; Aron and Poldrack 2005; Bellgrove et al. 2006; Durston et al. 2008; Fillmore and Rush 2002; Fillmore et al. 2002, 2006; Gauggel et al. 2004; Monterosso et al. 2005; Nigg et al. 2004; Oosterlaan e…”
BackgroundSelf-citationCatecholamine Influences on Dorsolateral Prefrontal Cortical Networks
Arnsten, A. F. T. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.027 · Cited by 493
Stimulants: Therapeutic Actions in ADHD
Arnsten, A. F. T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301164 · Cited by 473
“The enhancing effects of a2A agonists are most evident in subjects with PFC dysfunction, and these compounds can be less efficacious and/or potent in young adult animals (Franowicz and Arnsten, 1998) or humans (Muller et al, 2005) with healthy endogenous noradrenergic systems.”
Background
Metadata
- Authors
- Müller, U., Clark, L., Lam, M. L., Moore, R. M., Murphy, C. L., Richmond, N. K., Sandhu, R. S., Wilkins, I. A., Menon, D. K., Sahakian, B. J., & Robbins, T. W.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Müller, Ulrich
- Venue
- Psychopharmacology
- Published
- 2005-08-03
- Volume
- 182
- Issue
- 2
- Pages
- 205-213
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2062092741
- Cited by
- 73
- References
- 65
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2017: 5 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 5 · 2012: 4
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Medical Research Council
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- guanfacine, alpha-2 adrenergic agonists, executive function, working memory, cognitive enhancement, blood pressure reduction, sedative effects, backward digit span, reaction time, healthy volunteers
- MeSH terms
- Adult, Attention Deficit Disorder with Hyperactivity, Blood Pressure, Cognition, Double-Blind Method, Humans, Male, Memory, Reaction Time, Guanfacine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.